As of June 2026, according to Mckesson's latest financial report, the company's current EPS (TTM) is $38.55. In 2026, the company recorded an earnings per share (EPS) of $38.55, which represents an increase compared to its EPS of $25.86 in 2025. Mckesson's earnings per share for the quarterly report ending on Mar 31, 2026 was $13.72.
The annual EPS in 2026 was $38.55, an increase of 49.1% from $25.86 in 2025. For the quarter ending Mar 31, 2026, the EPS was $13.72, showing a 37.5% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of March 2026 is $38.55. In 2025, the annual EPS was $25.86, showing an increase of 14.7% from 2024.
Mckesson has recorded an increase in EPS of 37.5% over the last 12 months (YoY, quarterly). For the last three years, MCK recorded an average annual EPS growth rate of 15.2%. Across the last decade, MCK had an average annual EPS growth of 14.7%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| MCK Mckesson Corp | 19.18 | 49.1% | 15.2% | N/A |
| HSIC Henry Schein Inc | 22.75 | 7.2% | -5.9% | 3.1% |
| CAH Cardinal Health Inc | 29.81 | 86.2% | N/A | N/A |
| ACH Accendra Health Inc. | N/A | -202.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.